File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Fulminant tumour lysis syndrome after nivolumab and ipilimumab treatment for hepatocellular carcinoma

TitleFulminant tumour lysis syndrome after nivolumab and ipilimumab treatment for hepatocellular carcinoma
Authors
Issue Date9-Jul-2025
PublisherWiley
Citation
International Journal of Hepatology, 2025 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/359716
ISSN
2023 Impact Factor: 1.5
2023 SCImago Journal Rankings: 0.417

 

DC FieldValueLanguage
dc.contributor.authorKwok, Gin Wai-
dc.contributor.authorFung, Tiffany Hoi Wing-
dc.contributor.authorYau, Thomas-
dc.date.accessioned2025-09-10T00:31:02Z-
dc.date.available2025-09-10T00:31:02Z-
dc.date.issued2025-07-09-
dc.identifier.citationInternational Journal of Hepatology, 2025-
dc.identifier.issn2090-3448-
dc.identifier.urihttp://hdl.handle.net/10722/359716-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofInternational Journal of Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleFulminant tumour lysis syndrome after nivolumab and ipilimumab treatment for hepatocellular carcinoma-
dc.typeArticle-
dc.identifier.doi10.1016/j.jhep.2025.06.030-
dc.identifier.eissn2090-3456-
dc.identifier.issnl2090-3456-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats